Clinical Trials Logo

Clinical Trial Summary

Pre-eclampsia is a disease characterized by placental damage leading to a cascade of complications during pregnancy. It is initially manifested by high blood pressure and the presence of albumin in the urine. It can lead to emergency hospitalization in severe cases and cause major complications or even death in the mother and the fetus. Several studies observing the outcome of patients with pre-eclampsia have shown an increased long-term cardiovascular risk in these patients, justifying regular medical follow-up with the treating physician and specialists, mainly cardiologists. The main objective of this research is to describe the cardiovascular risk assessment actions implemented by the treating general practitioner in the year following pre-eclampsia (blood pressure measurement in the office, self-measurement of blood pressure, ABPM, cardiological consultation, biological monitoring of blood (creatininemia, LDL, fasting glycemia) or urine (albuminurie/creatininurie ratio), and screening and management of possible smoking).


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06059937
Study type Observational
Source Central Hospital, Nancy, France
Contact Jean Marc Boivin, MD-PhD
Phone 3 83 15 73 22
Email jm.boivin@chru-nancy.fr
Status Not yet recruiting
Phase
Start date October 2023
Completion date October 2024